We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Novosanis and University of Antwerp Receive Prestigious James Dyson Award
Product News

Novosanis and University of Antwerp Receive Prestigious James Dyson Award

Novosanis and University of Antwerp Receive Prestigious James Dyson Award
Product News

Novosanis and University of Antwerp Receive Prestigious James Dyson Award


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Novosanis and University of Antwerp Receive Prestigious James Dyson Award"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Novosanis has received the James Dyson Award as a national winner for its VAX-ID device. The device allows for injection in the dermal layer of the skin, which provides a better immune response because of the presence of dendritic cells in the skin.

A team of students and researchers from the University of Antwerp (Product Development and VAXINFECTIO) joint forces with Voxdale, a design and engineering company from Antwerp, to develop VAX-ID. One of the students of the team, Timothi Van Mulder, joint Novosanis as researcher medical development in July 2013. Another student of the team, Ruben Camerlynck, applied for the James Dyson award as the unique device offers a solution to a societal problem, i.e. providing vaccination to developing countries by use of a cost-efficient and easy-to-use device.

Koen Beyers, Chief Technology Officer at Novosanis, “it was a pleasure to inspire Ruben Camerlynck as a student and joining forces with a multidisciplinary team to generate a state-of-the-art device. It has been an exciting process and we are extremely pleased with the products’ unique architecture, smart mechanisms, and use of materials.”

Novosanis and University of Antwerp are extremely pleased with this prestigious award. The award encourages Novosanis to further develop the VAX-ID device as part of a platform of intradermal injection devices for which the company recently also received a grant from the Institute for Science and Technology Flanders (IWT).

Advertisement